This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Marco Minuth, PhD
Director Oligo R&D II at Bachem
Speaker

Profile

Marco Minuth is Director Oligo R&D II at Bachem. He received his PhD in organic chemistry from the University of Stuttgart investigating C-nucleosides for high-fidelity base pairing. He joined Bachem in 2015 as a project chemist in the API division. Since then, he had stages as Group Leader for peptide and later Senior group leader for oligonucleotide CMC development.

Agenda Sessions

  • Going Large-scale with Manufacturing of Oligonucleotides

    12:05pm